Melrose Industries logo

Melrose Industries

MLSPF | OTC
Chart Builder DCF Calculator
$6.60
+$0.20 (+3.12%)
At close: Sep 22, 2026, 3:40 PM ET
$6.40
-$0.20 (-3.03%)
After-hours: Sep 21, 2026, 4:00 PM ET
+3.12%

Rating

Updated: Sep 17, 2026
40.5
Fundamentals Average
Market Sentiment Neutral
Moat Narrow

Key Statistics

Market Data

Market Cap $8.22B
1D Range
6.39 6.70
52W Range
5.79 9.60

Valuation (TTM)

PE 20.57
PB 2.04
EV/EBITDA 9.08

Valuation (NTM)

Forward PE 10.40
Forward PEG 1.23
Price Target N/A
Loading financial charts...

Profile

A detailed description of the company is not yet available.

Sector n/a
Industry n/a
Employees n/a
IPO Date n/a
Website n/a
Fiscal Year n/a

Latest News

Melrose Industries: Clarity On Garden Grove Is Positive, But Uncertainties Remain

29 days ago · seekingalpha.com

Melrose Industries: Clarity On Garden Grove Is Positive, But Uncertainties Remain
Banks take different views on Melrose after Garden Grove claims programme

29 days ago · proactiveinvestors.co.uk

Banks take different views on Melrose after Garden Grove claims programme
Melrose Industries: Strong Buy Despite A Major New Risk

1 month ago · seekingalpha.com

Melrose Industries: Strong Buy Despite A Major New Risk
Melrose Industries outlines $100 million claims programme as Garden Grove moves towards restart

1 month ago · proactiveinvestors.co.uk

Melrose Industries outlines $100 million claims programme as Garden Grove moves towards restart
Melrose Industries PLC (MLSPF) Q2 2026 Earnings Call Transcript

2 months ago · seekingalpha.com

Melrose Industries PLC (MLSPF) Q2 2026 Earnings Call Transcript
Melrose Industries H1 Earnings Call Highlights

2 months ago · marketbeat.com

Melrose Industries H1 Earnings Call Highlights
Melrose shares fall 3.5% as Garden Grove incident drives £30m exceptional cost outlook

2 months ago · proactiveinvestors.com

Melrose shares fall 3.5% as Garden Grove incident drives £30m exceptional cost outlook
Futura Medical gets greenlight for stronger product "Eroxon Intense"

2 months ago · proactiveinvestors.com

Futura Medical gets greenlight for stronger product "Eroxon Intense"
BofA backs Melrose Industries with shares near year low

3 months ago · proactiveinvestors.co.uk

BofA backs Melrose Industries with shares near year low

Earnings

Next Earnings
Mar 4, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

© 2026 bestshares.com. All rights reserved.